$0.189900
-0.0038-1.96%
At close: -
$0.200000
0.015.32%
After Hours: 7:00 AM EDT
Comments
Loading...
Coeptis Therapeutics (COEP) Forecast
NewsEarningsCoeptis Therapeutics (COEP) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCoeptis Therapeutics (NASDAQ:COEP) Stock Quotes, Forecast and News Summary
Coeptis Therapeutics Stock (NASDAQ: COEP) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Coeptis Therapeutics (COEP) stock?
You can purchase shares of Coeptis Therapeutics (NASDAQ:COEP) through any online brokerage.
Who are Coeptis Therapeutics (COEP) competitors?
Other companies in Coeptis Therapeutics’s space includes: Vincerx Pharma (NASDAQ:VINC), Syros Pharmaceuticals (NASDAQ:SYRS), Galecto (NASDAQ:GLTO), T2 Biosystems (NASDAQ:TTOO) and Addex Therapeutics (NASDAQ:ADXN).
What is the forecast, or price target, for Coeptis Therapeutics (COEP) stock?
Coeptis Therapeutics has a consensus price target of $5.67.
What is the current price for Coeptis Therapeutics (COEP)?
The stock price for Coeptis Therapeutics (NASDAQ: COEP) is $0.2 last updated November 21, 2024 at 7:00 AM EST.
Does Coeptis Therapeutics (COEP) pay a dividend?
There are no upcoming dividends for Coeptis Therapeutics.
When is Coeptis Therapeutics (NASDAQ:COEP) reporting earnings?
Coeptis Therapeutics’s Q3 earnings are confirmed for Wednesday, November 13, 2024.
Is Coeptis Therapeutics (COEP) going to split?
There is no upcoming split for Coeptis Therapeutics.
What sector and industry does Coeptis Therapeutics (COEP) operate in?
Coeptis Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.